Scientists from the University of St Andrews reveal a new tuberculosis (TB) therapeutics that could shorten the treatment of the disease by up to two months, potentially saving millions of lives. Dr.

Tuberculosis (TB) was the leading cause of death in the United States in the 19th and 20th centuries. By 1900, TB—which usually attacks the lungs but can affect almost any part of the body—had killed ...

When you have a contagious disease like tuberculosis (TB), refusing treatment and refusing to isolate are not personal choices. Such choices affect not only you but also everyone around you, at least ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

As of early 2025, tuberculosis cases are increasing in the U.S. This disease, often shortened to TB, causes significant lung damage and, if not treated, is almost always lethal. World TB Day on March ...

Researcher found that exposed individuals with confirmed TB infection -- i.e. a positive skin or blood test -- should receive priority treatment in settings with a low prevalence of the disease, ...

Tuberculosis treatment adherence—consistent and complete intake of prescribed anti-tubercular drugs—is central to achieving favourable outcomes, including cure, prevention of relapse and avoidance of ...

The Centers for Disease Control and Prevention (CDC) estimates that up to 13 million people in the United States have latent tuberculosis (TB) infection. These patients do not feel sick, do not show ...

An international trial exploring the effectiveness of tuberculosis (TB) treatment in children has led to a change in the World Health Organization's global guidelines for managing the disease. A ...

The Northern Kentucky Health Department said they are in the process of contacting people who could have been exposed to the ...